|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Premium finance contracts and related receivable, net of allowance for credit losses of $2,514,737 and $2,202,768 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Finance lease assets | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| TOTAL OTHER ASSETS | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Cash overdraft | ||||||||||||||||||||
| Line of credit, net | ||||||||||||||||||||
| Drafts payable | ||||||||||||||||||||
| Note payable - current portion | ||||||||||||||||||||
| Note payable - stockholders and related parties - current portion | ||||||||||||||||||||
| Payroll Protection Program loan - current portion | ||||||||||||||||||||
| Other loans - current portion | ||||||||||||||||||||
| Operating lease obligation - current portion | ||||||||||||||||||||
| Finance lease obligation - current portion | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| LONG-TERM LIABILITIES | ||||||||||||||||||||
| Note payable, net of current portion | ||||||||||||||||||||
| Payroll Protection Program loan, net of current portion | ||||||||||||||||||||
| Note payable - stockholders and related parties, net of current portion | ||||||||||||||||||||
| Other loans, net of current portion | ||||||||||||||||||||
| Life insurance policy loan | ||||||||||||||||||||
| Operating lease obligation, net of current portion | ||||||||||||||||||||
| Finance lease obligation, net of current portion | ||||||||||||||||||||
| TOTAL LONG-TERM LIABILITIES | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Preferred stock, par value $0.001 per share; 20 million shares authorized, 600,000 shares designated as Series A - convertible, 166,000 issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Total preferred stock, par value $0.001 per share; 20 million shares authorized, 600,000 shares designated as Series A - convertible, 166,000 issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, par value $0.001 per share; 100 million shares authorized,2,930,726 and 3,001,216 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
